logo

For the Inventor, By the Inventor

Frankfurt, Germany

Alexander Knuth

This inventor holds 23 USPTO granted patents, primarily in Cancer Immunotherapy. Top assignees: Ludwig Institute for Cancer Research Limited, Cornell University, Memorial Sloan Kettering Cancer Center. Active years: 2000-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Knuth. Retrieved from https://idiyas.com/inventor/alexander-knuth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 23

% Patents Active = 47.8

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 75(Granted Patents)


Location History:

  • Zurich, CH (2008 - 2010)
  • Frankfurt-am-Main, DE (2000 - 2013)

Company Filing History:

goldMedal19 out of 530 
 
Ludwig Institute for Cancer Research Limited
 patents
silverMedal7 out of 2,954 
 
Cornell University
 patents
bronzeMedal5 out of 621 
 
Memorial Sloan Kettering Cancer Center
 patents
4. 4 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2013

Loading Chart...
Areas of Expertise:
Cancer Immunotherapy
NY-ESO-1 Protein
Cancer-Associated Antigens
Antibody Detection
Granulocyte-Macrophage
MHC Class I
MHC Class II
Peptides
Nucleic Acid Molecules
Immunogenic Molecules
SSX Family Proteins
Disease-Associated Antibodies
23 patents (USPTO):Explore Patents
1. 8541202 - Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein (2013-09-24),
2. 8142786 - Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein (2012-03-27),
3. 8071717 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof (2011-12-06),
4. 7888100 - Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 protein (2011-02-15),
5. 7795409 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof (2010-09-14),
6. 7795379 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof (2010-09-14),
7. 7622568 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof (2009-11-24),
8. 7354992 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof (2008-04-08),
9. 7291335 - Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof (2007-11-06),
10. 7132507 - Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses (2006-11-07),
11. 7125681 - Methods for detection of disease-associated antibodies in urine (2006-10-24),
12. 7115729 - Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 (2006-10-03),
13. 7009035 - Isolated peptides which bind to HLA-C molecules and uses thereof (2006-03-07),
14. 6911529 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof (2005-06-28),
15. 6830924 - Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof (2004-12-14),

Title: The Innovative Journey of Inventor Alexander Knuth

Introduction:

Alexander Knuth is a prolific inventor based in Frankfurt am Main, DE, known for his groundbreaking contributions to the field of biomedicine. With a total of 23 patents to his name, Knuth is a driving force behind cutting-edge research and development in the healthcare sector.

Latest Patents:

Among his latest patents is the "Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein." This innovative method revolves around peptides that effectively bind to MHC Class I and MHC Class II molecules, showcasing a promising avenue for therapeutic and diagnostic applications in various medical settings.

Career Highlights:

Knuth has been instrumental in advancing scientific discoveries during his tenure at renowned institutions such as the Ludwig Institute for Cancer Research and the Cornell Research Foundation Inc. His expertise and dedication have led to numerous breakthroughs that have the potential to revolutionize the treatment of various diseases.

Collaborations:

Throughout his career, Knuth has collaborated closely with esteemed colleagues such as Yao-tseng Chen and Ali O. Gure. Together, they have shared insights, conducted research, and pushed the boundaries of innovation to develop novel solutions that address critical healthcare challenges.

Conclusion:

Inventor Alexander Knuth's unwavering commitment to scientific excellence and his remarkable contributions to the field underscore his status as a trailblazer in biomedical innovation. With a diverse portfolio of patents and a legacy of collaboration with top-tier professionals, Knuth continues to drive forward progress in the realm of healthcare technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…